Which factors are associated with the application of reperfusion therapy in ST-elevation acute coronary syndromes?. Lessons from the Euro Heart Survey on Acute Coronary Syndromes I

Cardiology
R NieuwlaatE Boersma

Abstract

A large proportion of patients with a ST-elevation acute coronary syndrome do not receive reperfusion therapy. In order to contribute to a better understanding of the clinical decision making process, we analyzed which factors are associated with the application of reperfusion therapy. From the Euro Heart Survey of Acute Coronary Syndromes I, 4,260 patients with ST-elevation acute coronary syndrome were selected for the current analysis, of which 1,539 (36%) patients received fibrinolysis and 904 (21%) primary percutaneous coronary intervention (PCI). The analysis contained 32 variables on demographics, medical history, admission parameters and reperfusion therapy. A short pre-hospital delay, arrival in a hospital with PCI facilities, severe ST-elevation, and participation in a clinical trial were the strongest predictors for receiving reperfusion therapy. Primary PCI was more likely to be performed than fibrinolysis in patients with a long pre-hospital delay, arriving in a hospital with PCI facilities, not participating in a clinical trial, and with at least one previous PCI. Hospital facilities and culture, pre-hospital delay and infarction size play a major role in management decisions regarding reperfusion therapy in ST-ele...Continue Reading

References

May 15, 1998·JAMA : the Journal of the American Medical Association·S B SoumeraiF Gobel
Mar 27, 1999·Journal of the American Medical Informatics Association : JAMIA·R N ShiffmanG J Corb
Aug 10, 2001·JAMA : the Journal of the American Medical Association·P Y LeeE D Peterson
Feb 28, 2002·The American Journal of Cardiology·Tobias HeerJochen Senges
Mar 12, 2002·JAMA : the Journal of the American Medical Association·Rajendra H MehtaUNKNOWN GAP Steering Committee of the American College of Cardiology
Oct 24, 2002·Journal of the American College of Cardiology·Audrey H WuUNKNOWN Second National Registry of Myocardial Infarction
Feb 1, 2003·European Heart Journal·Frans Van de WerfUNKNOWN Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology
Apr 30, 2003·Archives of Internal Medicine·Ulf StenestrandUNKNOWN Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA)
May 3, 2003·European Heart Journal·Anna NorhammarUNKNOWN Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA)
Aug 22, 2003·The New England Journal of Medicine·Henning R AndersenUNKNOWN DANAMI-2 Investigators
Jan 28, 2004·Circulation·Philippe Gabriel StegUNKNOWN Global Registry of Acute Coronary Events Investigators

❮ Previous
Next ❯

Citations

Dec 7, 2013·Cellular and Molecular Life Sciences : CMLS·Lorenz H LehmannJohannes Backs
Jul 31, 2013·Herz·H MöllmannC Hamm
Jul 28, 2012·Der Internist·H MöllmannC Hamm
Jul 28, 2013·La Presse médicale·Etienne PuymiratNicolas Danchin
May 6, 2008·Health Services Research·Robert D Lieberthal
Sep 6, 2007·Progress in Cardiovascular Nursing·Mattie LenzenMaarten L Simoons
Jul 8, 2011·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·William B BordenJohn J Lopez
Aug 26, 2016·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Martin R CowieAndrew Zalewski

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.